EUVD-2023-41495

Malicious code in bioql PyPI...

CVE-2023-37613

A cross-site scripting XSS vulnerability in Assembly Software Trialworks v11.4 allows attackers to execute arbitrary web scripts or HTML via injecting a crafted payload into the asset src parameter...

CVE-2023-37613

A cross-site scripting XSS vulnerability in Assembly Software Trialworks v11.4 allows attackers to execute arbitrary web scripts or HTML via injecting a crafted payload into the asset src parameter...

CVE-2023-37613

A cross-site scripting XSS vulnerability in Assembly Software Trialworks v11.4 allows attackers to execute arbitrary web scripts or HTML via injecting a crafted payload into the asset src parameter...

Cross site scripting

A cross-site scripting XSS vulnerability in Assembly Software Trialworks v11.4 allows attackers to execute arbitrary web scripts or HTML via injecting a crafted payload into the asset src parameter...

CVE-2023-37613

CVE-2023-37613 describes an XSS vulnerability in Assembly Software Trialworks v11.4, where an attacker can inject a crafted payload into the asset src parameter to execute arbitrary web scripts/HTML in the victim’s browser. The connected sources consistently identify the affected product/version ...

PT-2023-26043 · Assembly · Trialworks

Name of the Vulnerable Software and Affected Versions: Assembly Software Trialworks version 11.4 Description: A cross-site scripting XSS issue allows attackers to execute arbitrary web scripts or HTML by injecting a crafted payload into the asset src parameter. This enables the execution of...

CVE-2023-37613

A cross-site scripting XSS vulnerability in Assembly Software Trialworks v11.4 allows attackers to execute arbitrary web scripts or HTML via injecting a crafted payload into the asset src parameter...